Comparison of Inflammatory Markers, Coagulation Indicators and Outcomes Between Influenza and COVID-19 Infection Amongst Children: A Systematic Review and Meta-analysis

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 May 20

PMID 38765052

Authors

Yutang Yang

Qi Zheng

Linlin Yang

Lei Wu

Affiliations

Soon will be listed here.

Abstract

Background: Influenza and COVID-19 patients share similar features and outcomes amongst adults. However, the difference between these diseases is not explored in paediatric age group especially in terms of inflammatory markers, coagulation profile and outcomes. Hence, we did this review to compare the inflammatory, coagulation features and outcomes between influenza and COVID-19 infected children.

Methods: Literature search was done in PubMed Central, Scopus, EMBASE, CINAHL, Cochrane library, Google Scholar & ScienceDirect from November 2019 to May 2022. Risk of bias assessment was done through Newcastle Ottawa scale. Meta-analysis was done using random-effects model and the final pooled estimate was reported as pooled odds ratio (OR) or standardized mean difference (SMD) along with 95 % confidence interval (CI) depending on the type of outcome.

Results: About 16 studies were included with most studies having higher risk of bias. Influenza paediatric patients had significantly higher erythrocyte sedimentation rate (ESR) (pooled SMD = 0.60; 95%CI: 0.30-0.91; I = 0 %), lactate dehydrogenase (LDH) (pooled SMD = 2.01; 95%CI: 0.37-3.66; I = 98.4 %) and prothrombin time (PT) (pooled SMD = 2.12; 95%CI: 0.44-3.80; I = 98.3 %) when compared to paediatric COVID-19 patients. There was no significant difference in terms of features like CRP, procalcitonin, serum albumin, aPTT, mortality and need for mechanical ventilation.

Conclusion: Inflammatory markers like ESR, LDH and PT was significantly higher in influenza patients when compared to COVID-19 in children, while rest of the markers and adverse clinical outcomes were similar between both the groups. Identification of these biomarkers has helped in understanding the distinctness of COVID-19 and influenza virus and develop better management strategies.

References

Yang Y, Tang H . Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia. Cell Mol Immunol. 2016; 13(4):432-42. PMC: 4947825. DOI: 10.1038/cmi.2016.1. View

Liang F, Wang X, Shao J, Chen J, Liu L, Li H . Comparison of clinical features on admission between coronavirus disease 2019 and influenza a among children: a retrospective study in China. BMC Infect Dis. 2021; 21(1):365. PMC: 8052833. DOI: 10.1186/s12879-021-06037-3. View

Asseri A, Shati A, Al-Qahtani S, Alzaydani I, Al-Jarie A, Alaliani M . Distinctive clinical and laboratory features of COVID-19 and H1N1 influenza infections among hospitalized pediatric patients. World J Pediatr. 2021; 17(3):272-279. PMC: 8108014. DOI: 10.1007/s12519-021-00432-1. View

Zhao Y, Sun D, Bouchard H, Zhang X, Wan G, Hao Y . Coronavirus Disease 2019 Influenza A in Children: An Observational Control Study in China. Biomed Environ Sci. 2020; 33(8):614-619. PMC: 7505108. DOI: 10.3967/bes2020.080. View

Liu X, Li W, Zhang B, Guo Y, Hu Z, Peng C . Comparative study of hospitalized children with acute respiratory distress syndrome caused by SARS-CoV-2 and influenza virus. BMC Infect Dis. 2021; 21(1):412. PMC: 8093914. DOI: 10.1186/s12879-021-06068-w. View

Lv X, Zhu Y, Cheng A, Jin Y, Ding H, Wang C . High serum lactate dehydrogenase and dyspnea: Positive predictors of adverse outcome in critical COVID-19 patients in Yichang. World J Clin Cases. 2020; 8(22):5535-5546. PMC: 7716337. DOI: 10.12998/wjcc.v8.i22.5535. View

Liu M, Han Y, Sun J, Wei X, Zhao X, Wang B . Comparison of the Epidemiological and Clinical Characteristics of Hospitalized Children With Pneumonia Caused by SARS-CoV-2, Influenza A, and Human Adenoviruses: A Case-Control Study. Clin Pediatr (Phila). 2021; 61(2):150-158. DOI: 10.1177/00099228211058601. View

Laris-Gonzalez A, Aviles-Robles M, Dominguez-Barrera C, Parra-Ortega I, Sanchez-Huerta J, Ojeda-Diezbarroso K . Influenza vs. COVID-19: Comparison of Clinical Characteristics and Outcomes in Pediatric Patients in Mexico City. Front Pediatr. 2021; 9:676611. PMC: 8264261. DOI: 10.3389/fped.2021.676611. View

Pormohammad A, Ghorbani S, Khatami A, Razizadeh M, Alborzi E, Zarei M . Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings. Rev Med Virol. 2020; 31(3):e2179. PMC: 7646051. DOI: 10.1002/rmv.2179. View

10.

Chong W, Saha B, Medarov B . A systematic review and meta-analysis comparing the clinical characteristics and outcomes of COVID-19 and influenza patients on ECMO. Respir Investig. 2021; 59(6):748-756. PMC: 8367736. DOI: 10.1016/j.resinv.2021.07.006. View

11.

Piroth L, Cottenet J, Mariet A, Bonniaud P, Blot M, Tubert-Bitter P . Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2020; 9(3):251-259. PMC: 7832247. DOI: 10.1016/S2213-2600(20)30527-0. View

12.

Mardani R, Namavar M, Ghorbi E, Shoja Z, Zali F, Kaghazian H . Association between serum inflammatory parameters and the disease severity in COVID-19 patients. J Clin Lab Anal. 2021; 36(1):e24162. PMC: 8761446. DOI: 10.1002/jcla.24162. View

13.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

14.

Pokorska-Spiewak M, Talarek E, Popielska J, Nowicka K, Oldakowska A, Zawadka K . Comparison of clinical severity and epidemiological spectrum between coronavirus disease 2019 and influenza in children. Sci Rep. 2021; 11(1):5760. PMC: 7952543. DOI: 10.1038/s41598-021-85340-0. View

15.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062. PMC: 7270627. DOI: 10.1016/S0140-6736(20)30566-3. View

16.

Li Y, Wang H, Wang F, Du H, Liu X, Chen P . Comparison of hospitalized patients with pneumonia caused by COVID-19 and influenza A in children under 5 years. Int J Infect Dis. 2020; 98:80-83. PMC: 7289729. DOI: 10.1016/j.ijid.2020.06.026. View

17.

Tang N, Li D, Wang X, Sun Z . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4):844-847. PMC: 7166509. DOI: 10.1111/jth.14768. View

18.

Neuzil K, Zhu Y, Griffin M, Edwards K, Thompson J, Tollefson S . Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis. 2002; 185(2):147-52. DOI: 10.1086/338363. View

19.

Hedberg P, Valik J, van der Werff S, Tanushi H, Mendez A, Granath F . Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data. Thorax. 2021; 77(2):154-163. PMC: 8260304. DOI: 10.1136/thoraxjnl-2021-216949. View

20.

Bai Y, Yao L, Wei T, Tian F, Jin D, Chen L . Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA. 2020; 323(14):1406-1407. PMC: 7042844. DOI: 10.1001/jama.2020.2565. View